Detalhe da pesquisa
1.
Homologous and Heterologous Covid-19 Booster Vaccinations.
N Engl J Med
; 386(11): 1046-1057, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35081293
2.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37561027
3.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37036397
4.
Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol.
BMC Pregnancy Childbirth
; 22(1): 402, 2022 May 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35550037
5.
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
N Engl J Med
; 386(11): 1088-1091, 2022 03 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35081298
6.
Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses.
J Immunol
; 196(5): 2205-2218, 2016 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26810224
7.
Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants.
Pediatrics
; 153(3)2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38332733
8.
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn.
Vaccine
; 41(36): 5296-5303, 2023 08 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37451878
9.
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
medRxiv
; 2023 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37034641
10.
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
medRxiv
; 2023 Jun 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37333252
11.
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
NPJ Vaccines
; 8(1): 98, 2023 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37433788
12.
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Nat Med
; 29(9): 2334-2346, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37640860
13.
Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons.
J Immunol
; 184(6): 3250-9, 2010 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20164419
14.
HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens.
Front Immunol
; 13: 867962, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35432373
15.
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004).
medRxiv
; 2022 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35734087
16.
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines.
bioRxiv
; 2022 Mar 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35313570
17.
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
Science
; 377(6608): 890-894, 2022 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35857529
18.
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.
medRxiv
; 2022 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35898343
19.
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
Cell Rep Med
; 3(7): 100679, 2022 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35798000
20.
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines.
Sci Immunol
; 7(78): eadf1421, 2022 12 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36356052